(Q82237213)
Statements
A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma (English)
Bleumer I
Oosterwijk E
Oosterwijk-Wakka JC
Völler MC
Melchior S
Warnaar SO
Mala C
Beck J